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ABSTRACT 
Background: Aristolochia bracteata (Lam.) is described in Ayurveda for the treatment of painful inflammations, cardiac disorders.  
Objectives: The present study was aimed to investigate the phytochemical, in vitro antihemolytic and anti-arthritic activities of ethanolic extracts of 
leaf, stem and root of A. bracteata. The phytochemical, in vitro antihemolytic and anti-arthritic activities of different parts of A. bracteata by 
standard protocols.  
Results: The various bioactive phytocompounds such as carbohydrates, flavonoids, saponins, steroids and coumarins present in leaf, stem and roots 
of A. bracteata. The maximum protection of RBC membrane lysis was observed in ethanolic extract of A. bracteata. The ethanolic extracts of stem 
exhibited significant protection of membrane denaturation and proteinase inhibitory activities.   
Conclusion: So, from this result indicates A. bracteata may be used in designing various pharmacological drugs and treatment of rheumatoid 
arthritis.  
Keywords: Aristolochia bracteata, Antihemolytic, Anti-arthritic, Protein denaturation,  ethanolic extract. 
 
 INTRODUCTION 
Herbal medicine has been commonly used over the years for 
treatment and prevention of diseases and health promotion and 
quality of life. However, there is a lack of a systematic approach to 
assess their safety and effectiveness. The holistic approach to health 
care makes herbal medicine very attractive to many people in 
worldwide. Herbal extracts may be contaminated, adulterated and 
may contain toxic compounds. The quality control of herbal 
medicines has a direct impact on their safety and efficacy1. The 
medicinal value of these plants lies in bioactive phytochemical 
constituents that produce definite physiological action on the human 
body2. Some of the most important bioactive phytochemical 
constituents are alkaloids, essential oils, flavonoids, tannins, 
terpenoids, saponins, phenolic compounds etc 3. Several herbal 
secondary metabolites such as flavonoids have been found to protect 
cells from oxidative damage. These compounds have been evidenced 
to stabilize RBC membrane by scavenging free radicals and reducing 
lipid peroxidation 4. These natural compounds formed the 
foundations of modern prescription drugs 5. 
Hemolysis is a destruction of erythrocytes with liberation of 
hemoglobin in plasma. Hemolysis occurs in a variety of pathological 
conditions such as autoimmunity against RBC-surface antigen, 
mechanical disruption of RBC, malaria/clostridium infection, 
thalassemia and sickle cell disease 6. Erythrocytes are exclusive 
blood cells that deliver oxygen to our body 7 and participate in 
detoxification of a great variety of toxic xenobiotics 8. Oxidative 
damage and hemolysis caused by reactive oxygen species (ROS) 
have a major role in the development of diseases such as 
thalassemia, glucose-6-phosphate dehydrogenase deficiency and 
sickle cell anemia. Red blood cells (RBCs) are the primary targets of 
free radicals, owing to their high membrane concentrations of 
polyunsaturated fatty acids (linoleic and arachidonic acids) O2 
transport associated with redox active hemoglobin molecules, which 
are potent promoters of ROS. Furthermore, RBCs are very 
susceptible to oxidative stress due to high cellular concentration of 
oxygen and hemoglobin, high polyunsaturated fatty acid content 
while oxidative stress on RBC is implicated to hemolysis 9. 
Erythrocytes, which are the most abundant cells in the human body, 
possessing desirable physiological and morphological 
characteristics, are exploited extensively in drug delivery 10. 
Oxidative damage to the erythrocyte membrane (lipid/protein) may 
be implicated in hemolytic associated with some 
hemoglobinopathies, oxidative drugs, transition metal excess, 
radiation and deficiencies in some erythrocyte antioxidant systems 
11. Many plants contain chemical substances that might have a 
hemolytic or antihemolytic effect on human erythrocytes. Several 
reports indicate that the membranes of human erythrocytes from 
blood types have varying stability as determined from the mean 
corpuscular fragility 12. Plant extracts can positively affect the red 
cell membrane13 and many plants have serious adverse effects, 
which include induction of hemolytic anemia. Therefore, many of the 
commonly used plants need to be evaluated for their potential 
hemolytic activity. 
Arthritis represents one of the most prevalent chronic health 
problems and is a leading cause of disability14. Arthritis affected 43 
million U.S. adults in 2002 and the year 2020, this number is 
expected to reach 60 million15. In Rheumatoid arthritis is the 
inflammation of a joint, osteoarthritis is the most common form of 
arthritis and associated with inflammation resulting from an 
overactive immune system. It is a degenerative disease 
characterized by damage to the articular cartilage, changes in 
subchondral and marginal bone, synovitis and capsular thickening, 
typically affecting weight bearing can include infiltration of 
inflammatory cells (monocytes), synovial hyperplasia, bone erosion 
and new bone formation, narrowing of the joint space and ankylosis 
of the joint16. Herbal plants and other traditional medicinal system 
for the treatment of various diseases. Hence, they play an important 
role as alternative medicine due to less side effects and low cost.  
Aristolochia bracteata is a perennial herb. This plant belongs to the 
family Aristolochiaceae. This species which had been shown to be 
nephrotoxic, mutagenic and carcinogenic due to the cytotoxicity of 
the Aristolochic acid constituents. The leaves of the plant which are 
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used by native tribal and the villagers. It is commonly called as 
worm killer in English and aadutheendapaalai in Tamil. It is used in 
traditional medicines as a gastric stimulant and in the treatment of 
cancer, lung inflammation, dysentery and snakebites. The whole 
plant was used as a purgative, anti pyretic and anti inflammatory. 
The plant contain Aristolochic acid has many medicinal properties in 
various disease condition. The root part was used to treat syphilis, 
gonorrhea and also used during labors to increase uterine 
contraction. The plant produced diverse range of bioactive 
molecules making them a rich source of different types of 
medicine17. There is no detailed on in vitro antihemolytic and anti-
arthritic activity of ethanolic extracts of leaf, stem and root of A. 
bracteata (Lam.).  
MATERIALS AND METHODS 
Collection of plant materials 
The fresh leaves of Aristolochia bracteata (Lam.) were collected in 
November 2016 from the village of Thirunanriyur, Nagappattinam 
(district), Tamilnadu. The plant was identified by Dr. S. John Britto, 
Director, Rapinat Herbarium and Centre for Molecular Systematics, 
Department of Botany, St. Joseph’s College, Tiruchirappalli, 
Tamilnadu, India. The collected leaves were cleaned well and air 
dried under shade at room temperature, the sample was powdered 
in an electric grinder, sieved with coarse powder and stored in air 
tight container. 
Preparation of extracts 
25 g of powdered materials were soaked in the 250 ml of ethanol 
and plug with cotton for 3 days and then filtered through muslin 
cloth followed by Whatmann No. 1 filter paper. The filtrates were 
concentrated by boiling water bath and then crude form of extracts 
was stored at    4 – 8 ºC in air tight container. 
Qualitative method of phytochemical screening  
The preliminary chemical tests were carried out for the extracts of 
Aristolochia bracteata (leaf, stem and root) to identify the presence 
of various phytoconstituents by using standard protocol [18]. 
In vitro antihemolytic activity 
Inhibitory effects on H2O2 induced erythrocyte hemolysis 
The antihemolytic activity was examined by the method of Naim et 
al.,19. The erythrocytes from cow blood were separated by 
centrifugation and washed with saline or isotonic sodium phosphate 
buffer (pH 7.4), until the supernatant was colorless. The 
erythrocytes were then diluted with saline or phosphate buffer to 
give a 4% suspension. Varying amounts of sample (200-1000 µg mL-
1) with saline or buffer were added to 2 mL of the suspension of 
erythrocytes and the volume was made up to 3.5 mL with saline or 
buffer. This mixture was preincubated for 5 min and then 0.5 mL of 
0.3% H2O2 solutions of appropriate concentration in saline or buffer 
was added. The concentration of H2O2 in the reaction mixture was 
adjusted so as to bring about 90 % hemolysis of blood cells after 120 
min incubation. Incubation was concluded after these time intervals 
by centrifugation at 1000 g for during 5 min. The extent of hemolysis 
was determined by measurement of the absorbance at 540 nm 
corresponding to hemoglobin liberation. 
  % antihemolysis = [(A0 – A1)/A0] x 100 
In vitro anti-arthritic activities 
Inhibition of protein denaturation 
The inhibition of protein denaturation was carried out by the 
method of Eduardo and Tannia 20. The test solution consisted of 0.45 
ml of Bovine serum albumin (5 % w/v aqueous solution) and 0.05 
ml of EA (100 and 250 µg/ml) in DMSO. Test control (0.5 ml) 
consisted of 0.45 ml of bovine serum albumin and 0.05 ml of distilled 
water. Whereas product control (0.5 ml) consisted of 0.45 ml of 
distilled water and 0.05 ml of EA and standard consisted of    0.45 ml 
of bovine serum albumin and 0.05 ml of acetyl salicylic acid. The 
samples were incubated at 37 ºC for 20 min and the temperature 
was increased to 57 ºC for 3 min. After cooling, 2.5 ml of phosphate 
buffer saline (pH 6.3) was added to each tube. The absorbance was 
measured spectrophotometrically at 660 nm. The control 
represented 100 % protein denaturation. The results were 
compared with acetyl salicylic acid. The percentage inhibition of 
protein denaturation was calculated as below: 
 Percent inhibition =     
100 - (OD of test solution – OD of product control)   X  100 
OD of test control 
Proteinase Inhibitory activity 
Proteinase inhibitory activity was carried out by the method of 
Chatterjee 21. The test solution (2.0 ml) contained 0.06 mg trypsin 1.0 
ml 25 mM tris-HCl buffer      (pH 7.4) and 1.0 ml of EA (100 and 250 
µg/ml) in DMSO and standard consisted of 0.5 ml Acetyl salicylic 
acid (250 µg/ml). The mixture was incubated at 37 ºC for 5 min. 
Then 1.0 ml of 0.8 % (w/v) casein was added. The mixtures were 
incubated for an additional 20 min and 2.0 ml of 70 % perchloric 
acid was added to terminate the reaction. Cloudy suspension was 
centrifuged and absorbance of the supernatant was read at 280 nm 
against buffer as blank. The product control lacked trypsin in 
reaction mixture and test control represented 100 % inhibition. The 
results were compared with acetyl salicylic acid (250 µg/ml) treated 
samples. The percentage inhibition of protein was calculated as 
below: 
Percent inhibition =    
100 - (OD of test solution – OD of product control)    X  100 
OD of test control 
RESULTS 
Phytochemical analysis 
The phytocompounds of A. bracteata were qualitative analyses from 
leaf, stem and root separately and result is mention in Table 1. The 
present study revealed that the ethanolic extracts of leaf, stem and 
root of A. bracteata contains the presence of various bioactive 
phytocompounds were rich in carbohydrates, flavonoids, saponins, 
steroids and coumarins. Secondary metabolites such as phenols and 
terpenoids present in the leaf and stem extracts of A. bracteata 
where as phlobataninns and anthraquinones were absent in all the 
three parts (leaf, stem and roots) of        A. bracteata. 
 
Antihemolytic activity 
The present study indicated that in vitro antihemolytic activity of 
ethanolic extracts of leaf, stem and root of A. bracteata (Lam.) shown 
in Table 2 and Fig. 1. In vitro RBC membrane destruction was 
induced by H2O2. The maximum protection of RBC membrane lysis 
(48.3 ±1.34) was observed in ethanolic extract of A. bracteata leaf 
when compared to stem and root extracts of A. bracteata. These 
results were compared with standard drug aspirin (58.3 ± 0.96 at 
1mg/ml). The minimum RBC protection (12.5 ±0.95) was observed 
in root extract at 200 µg of A. bracteata. Antihemolytic activity was 
increased with increasing concentration of plant extracts (Plate 1,2 
and 3). 
 
Plate 1: Antihemolytic activity of A. bracteata (Lam.) leaf 
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Plate 2: Antihemolytic activity of A. bracteata (Lam.) stem 
 
Plate 3: Antihemolytic activity of A. bracteata (Lam.) root 
 
Table 1: The phytochemical analysis of ethanolic extracts of A. bracteata (Lam.) 
Name of the phytocompounds Different parts of A. bracteata 
Leaf Stem Root 
Alkaloids - - - 
Carbohydrates +++ +++ +++ 
Glycosides +++ - - 
Proteins + + + 
Steroids ++ +++ + 
Tannins + - - 
Phenols +++ ++ - 
Flavonoids ++ ++ + 
Coumarins ++ ++ + 
Saponins + +++ ++ 
Quinines - - ++ 
Terpenoids + ++ - 
Phlobatannins - - - 
Anthraquinones - - - 
+++ highly;  ++ moderate;  + mild;  - absent;  + present. 
 
Table 2: In vitro antihemolytic activity of ethanolic extracts of A. bracteata (Lam.) 
Concentration of plant extracts 
(µg/ml) 
% of anti hemolytic activity 
       Leaf        Stem Root Aspirin 
200 26.6 ± 0.98 21.6 ± 0.95 12.5 ± 0.95 - 
400 35    ± 0.94 30    ± 0.94 15    ± 0.94 - 
600 43.3 ± 0.94 36    ± 2.41 17.5 ± 1.20 - 
800 46    ± 0.94 38    ± 1.69 20    ± 1.41 - 
1000 48.3 ± 1.34 42    ± 1.18 27.5 ± 1.20 58.3 ± 0.96 
Values are expressed as mean ± S.E (n=3) 
 
 
Values are expressed as mean ± S.E (n=3) 
Fig. 1: In vitro antihemolytic activity of ethanolic extracts of A. 
bracteata (Lam.) 
Anti-arthritic activity 
The production of auto antigen in certain arthritic disease may be 
due to denaturation of protein activity. In the present study showed 
that the ethanol extracts of different parts of  A. bracteata (Lam.) 
against albumin denaturation in Table 3 and Fig. 2. The anti-arthritic 
activity was significantly decreased at the increasing concentration 
of plant extracts. The highest inhibition of protein denaturation 
(95.5 ±1.32) was observed in stem extract of A. bracteata at 200 µg 
and the minimum inhibition (59.4 ± 0.85) was observed in stem at 
the concentration 1000 µg, which was compared to ethanolic 
extracts of leaf and root of A. bracteata and standard drug aspirin.  
 
Values are expressed as mean ± S.E (n=3) 
Fig. 2: In vitro protein denaturation of ethanolic extracts of A. 
bracteata (Lam.) 
Proteinase inhibition 
Proteinase that begins the hydrolytic breakdown of proteins by 
splitting into polypeptide chains. The maximum percentage of 
proteinase inhibitory activity was showed in all three parts of A. 
bracteata at 200 µg/ml as shown in Table 4 and Fig. 3.  From this 
result, ethanolic extracts of stem has maximum proteinase inhibitory 
activity (88.8 ± 0.61) was observed in 200 µg, when compared to 
root extracts of A. bracteata. The minimum inhibition of protein lysis   
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(60 ± 0.47) was observed in leaf extracts of A. bracteata. The activity was decreased at increasing concentration of plant extracts. 
 
Table 3: In vitro protein denaturation of ethanolic extracts of A. bracteata (Lam.) 
 
Concentration of plant extracts (µg/ml) 
 
 
% of protein denaturation 
Leaf Stem Root Aspirin 
200 95 ± 0.94 95.5 ± 1.32 91.6 ± 0.98 - 
400 90 ± 1.70 90.9 ± 1.22 83.3 ±1.23 - 
600 80 ± 0.47 77.2 ± 0.99 79.1 ± 1.20 - 
800 70 ± 0.94 63.7 ± 2.61 75 ± 1.41 - 
1000 60 ± 1.88 59.4 ± 0.85 66.6 ± 1.50 72.8 ± 2.96 
Values are expressed as mean ± S.E (n=3) 
 
Table 4: In vitro proteinase inhibitory activity of ethanolic extracts of A. bracteata (Lam.) 
 
Concentration of plant extracts (µg/ml) 
                        % of Proteinase inhibition 
Leaf Stem Root Aspirin 
200 60 ± 0.47 88.8 ± 0.61 65 ± 0.94  
400 56 ± 0.94 72.3 ± 1.06 55 ± 1.41  
600 44 ± 1.41 55.6 ± 1.08 45 ± 1.88  
800 36 ± 1.88 44.5 ± 1.55 40 ± 0.47  
  1000 28 ± 0.94 33.4 ± 1.57 35 ± 0.94 72.2 ± 1.03 
Values are expressed as mean ± S.E (n=3) 
 
 
 Values are expressed as mean ± S.E (n=3) 
Fig. 3: In vitro proteinase inhibitory activity of ethanolic 
extracts of A. bracteata (Lam.) 
DISCUSSION 
The variation in type of phytochemicals present in different solvents 
as shown in the result of phytochemical screening might be 
attributed to the ability of the solvents to dissolve into solution 
specific type of secondary metabolites as reported by Yusha’u et 
al.22. Bharathajothi and Bhaaskaran23 also reported the similar result 
were observed in ethanolic extracts of Aristolochia bracteata (Lam.), 
Deepa et al.24 also reported the phytochemical analysis of aqueous 
and methanolic extracts of Aristolochia bracteata leaf. Phenolic 
compounds are a large and complex group of chemical constituents 
found in plants25. They are plant secondary metabolites, and they 
have an important role as defense compounds. Phenolics exhibit 
several properties that are beneficial to humans, and its antioxidant 
properties are important in determining their role as protective 
agents against free radical mediated disease processes. Flavonoids 
are a phenolic structure containing one carbonyl group complexes 
with extracellular and soluble proteins and with bacterial cell wall26. 
The phytochemical analysis of ethanolic extracts of leaf, stem and 
root of A. bracteata contains carbohydrates, phenols, tannins, 
flavonoids, saponins, glycosides, coumarins, terpenoids and steroids 
were highly present in leaf extract of plant, when compared to stem 
and root extracts of A. bracteata. 
Hemolysis is due to red blood cells destruction which resulted from 
lysis of membrane lipid bilayer. This hemolysis relates to 
concentration and potency of plant extracts. The erythrocyte model 
has been widely used as a direct indication of toxicity of injectable 
formulations as well as general indication of membrane toxicity. 
Another advantage of erythrocytes model that blood is readily 
available and RBC cells are easy to isolate from the blood; moreover, 
its membrane has similarities with other cell membranes27. 
Erythrocytes have been used as a model system by a number of 
workers for the study of interaction of drugs with membranes28.  
During its lifetime of ~120 days, the red blood cell (RBC) is exposed 
to continuous oxidative stress. It is particularly susceptible to 
oxidative damage due to the high content of unsaturated fatty acid 
chains in the lipid bilayer29 combined with high oxygen levels, as 
well as protein susceptibility to oxidative processes. Hydrogen 
peroxide generated during the autoxidation of oxyhemoglobin 
contributes to heme degradation thus the reactive oxygen species is 
a good model to study experimentally-induced erythrocyte 
damages30. It has been suggested that phytochemicals can either 
protect erythrocytes or increase their resistance to oxidative 
reaction 31. 
Erythrocytes are considered as prime targets for free radical attack, 
owing to the presence of both high membrane concentration of 
polyunsaturated fatty acids (PUFA) and the O2 transport associated 
with redox active hemoglobin molecules, which are potent 
promoters of reactive O2 species, especially linoleic acid and 
arachidonic acid are targets of lipid peroxidation32. Erythrocytes are 
the most abundant cells in the human body possess desirable 
physiological and morphological characteristics10. The capability of 
different phenolic substances to scavenge various types of oxidation-
initiating radicals has been reported in the polar phase33. It was 
demonstrate that binding of the flavonoids to the RBC membranes 
significantly inhibits lipid peroxidation, and at the same time 
enhances their integrity against lyses34. Scavenging of H2O2 by A. 
bracteata extract may be attributed to its phenolics and other active 
components which can donate electrons to H2O2, thus neutralizing it 
to water35. The maximum protection of RBC membrane lysis was 
seen in leaf extract of A. bracteata may be due to the presence of 
flavonoids, phenolics and other phytocompounds are scavenging 
H2O2 induced the free radical formation in RBC.  
RA is considered as a chronic systemic autoimmune disease with the 
main characteristic of chronic joint inflammation that ultimately 
leads to joint destruction. In vitro anti-arthritic activity when tested 
using standard methods. However, treatment with plant extracts 
although may be have some unpredictability in the effectiveness; 
being non-toxic and less side effect as compared to other system of 
medicine, many medicinal plants have proven effects on arthritic 
symptoms as compared to that of conventional medicines36.  
Denaturation of tissue proteins is one of the well documented causes 
of inflammatory and arthritic diseases. Production of auto-antigens 
in certain arthritic diseases may be due to denaturation of proteins 
in vivo. The mechanism of denaturation probably involves alteration 
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of electrostatic hydrogen, hydrophobic and disulphide bonding. The 
increments in absorbance of plant extract and reference drug with 
respect to control indicated the stabilization of albumin protein. This 
anti-denaturation effect was further supported by the change in 
viscosities. It has been reported that the viscosities of protein 
solutions increase on denaturation37. The ethanolic extracts of A. 
bracteata controlling the formation of auto antigen and inhibit the 
protein denaturation was observed in stem. The inhibition of protein 
denaturation was decreased at increasing concentration of plant 
extracts. Similarly, Shruthi et al., 38 also observed in anti-arthritic 
activity of ellagic acid isolated from methanolic extracts of Kirganelia 
reticulate leaf. 
In the present study, the ethanolic extract of A. bracteata contains 
several phytochemicals such as terpenoids, alkaloids, glycosides, 
flavonoids and steroids. The presence of these phytocompounds 
may be attributing to its anti-rheumatic activity through the anti-
inflammatory activity as well as modifying the autoimmune system. 
It can be stated that ethanolic extracts are capable of controlling the 
production of auto antigen and inhibits denaturation of protein and 
membrane lysis in rheumatic disease 39. 
Proteinases have been implicated in arthritic reactions. Neutrophils 
are known to be a source of proteinase, which carries in their 
lysosomal granules many serine proteinases. It was previously 
reported that leukocytes proteinase play important role in the 
development of tissue damage during in inflammatory reactions and 
significant level of protection was provided by proteinase inhibitors 
40. Similarly, Shruthi et al., 38 also observed in anti-arthritic activity of 
ellagic acid isolated from methanolic extracts of Kirganelia reticulate 
leaf. So we purified plant extracts and their isolated 
phytoconstituents can be very useful against rheumatoid arthritis. 
CONCLUSION 
In this study the phytochemical and in vitro antihemolytic and anti-
arthritic activities of ethanolic extracts of A. bracteata. The 
phytochemical analysis of ethanolic extracts of leaf, stem and root of 
A. bracteata contains pharmacological active phytoconsistutents 
were highly present in leaf extract of plant, when compared to stem 
and root extracts of A. bracteata. In vitro antihemolytic activity of 
ethanolic extracts of A. bracteata was evaluated against hydrogen 
peroxide-induced hemolysis of erythrocytes (RBC). The minimum 
lysis was observed in leaf extracts of A. bracteata. In this present 
study, the maximum inhibition of protein denaturation and 
proteinase inhibitory activities were showed in stem of A. bracteata, 
when compared to leaf and root of A. bracteata. These results 
showed that the presence of active principles in ethanolic extracts of 
different parts of A. bracteata. Therefore, further investigation is 
required to isolate the pure bioactive phytocompounds may be 
responsible for antihemolytic and anti-arthritic activities. 
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